Efficacy and Safety of PD-1/PD-L1 Inhibitors in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

• Главные авторы: Zhen-Yu Li (Автор), Zhen Zhang (Автор), Xiao-Zhong Cao (Автор), Yun Feng (Автор), Sha-Sha Ren (Автор)
• Формат: ‌
• Опубликовано: IMR Press, 2023-09-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: Compared with other subtypes, triple-negative breast cancer (TNBC) is more aggressive and has a lower survival rate with chemotherapy being the only acknowledged systemic treatment option. Recently, PD-1/PD-L1 (programmed cell death-1 and programmed death-ligand 1) inhibitors have demons...